EVOGENE LTD. (EVGN) Stock Price
EVGNStock
$0.39−69.83%52W
Market Cap$6.10M
P/E—
PEG Ratio—
Div yield—
Beta1.41
EVGN Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-62.81%
Price vs S&P 500 (4W)-15.26%
VGM Score51.11
EVGN Earnings Surprise History
| Quarter | Report date | EPS estimate | EPS actual | Surprise |
|---|---|---|---|---|
| Q2 2026 | -$0.27 | -$0.13 | +51.67%(+$0.14) | |
| Q1 2026 | -$0.27 | -$0.61 | -125.74%(-$0.34) | |
| Q4 2025 | -$0.26 | -$0.62 | -137.46%(-$0.36) | |
| Q3 2025 | -$0.41 | -$0.46 | -13.39%(-$0.05) | |
| Q2 2025 | -$0.63 | -$0.50 | +20.63%(+$0.13) |
EVGN Analyst Recommendations
Jun 2026
Jul 2026
Aug 2026
Sep 2026
4.14
4.14
4.14
4.14
Industry Peers — Agricultural Chemicals(11)
| Symbol | Value Score | Growth Score | Momentum Score | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|---|---|---|
EVGNEVOGENE LTD. | C | B | D | 5.3x | 331.5% | 71.0% | — | $0.39 |
| NTRNutrien Ltd. Common Shares | B | B | A | 1.2x | 8.6% | 31.0% | 42.1% | $71.26 |
| CFCF Industries Holding, Inc. | B | B | A | 2.4x | 20.0% | 42.5% | 43.5% | $120.85 |
| ICLICL Group Ltd. | B | C | B | 1.1x | -18.2% | 30.5% | 82.7% | $4.97 |
| MOSThe Mosaic Company | B | C | C | 0.5x | 8.8% | 11.0% | -0.6% | $18.82 |
| SMGThe Scotts Miracle-Gro Company | B | D | B | 0.9x | -1.9% | 32.5% | -18.3% | $54.57 |
| UANCVR Partners, LP | B | B | A | 2.0x | 17.5% | 46.1% | — | $126.36 |
| CBUSCibus, Inc. Class A Common Stock | D | D | C | 23.2x | -10.3% | 100.0% | — | $1.32 |
| AVDAmerican Vanguard Corporation | B | D | F | 0.1x | -3.5% | 29.4% | — | $1.06 |
| BIOXBioceres Crop Solutions Corp. Ordinary Shares | B | C | D | 0.1x | -10.1% | 35.7% | — | $0.28 |
| FRTTFort Technology Inc. Common Shares | — | — | D | — | — | — | — | $0.54 |
About EVOGENE LTD.
Evogene Ltd is a computational biology company that uses its Computational Predictive Biology platform to discover and develop life-science products based on microbes, small molecules, and genetic elements. The company operates across three sectors—agriculture, human health, and industrial applications—through a portfolio of subsidiaries developing agricultural biologicals, seed traits, microbiome therapeutics, and specialty chemicals. Revenue is generated primarily from the agriculture segment.